Hepatobiliary mucinous cystadenoma resulting in biliary obstruction.

Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study.

Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study.

[Anonymous].  2015.  Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study.. Clinical transplantation. 29(9):796-805.

N-Aryl benzenesulfonamide inhibitors of 3H -thymidine incorporation and β-catenin signaling in human hepatocyte-derived Huh-7 carcinoma cells.

N-Aryl benzenesulfonamide inhibitors of 3H -thymidine incorporation and β-catenin signaling in human hepatocyte-derived Huh-7 carcinoma cells.

[Anonymous].  2015.  N-Aryl benzenesulfonamide inhibitors of 3H -thymidine incorporation and β-catenin signaling in human hepatocyte-derived Huh-7 carcinoma cells.. Bioorganic & medicinal chemistry letters. 25(18):3897-9.

A prospective analysis of factors associated with decreased physical activity in patients with cirrhosis undergoing transplant evaluation.

A prospective analysis of factors associated with decreased physical activity in patients with cirrhosis undergoing transplant evaluation.

[Anonymous].  2015.  A prospective analysis of factors associated with decreased physical activity in patients with cirrhosis undergoing transplant evaluation.. Clinical transplantation. 29(11):958-64.

Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.

Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.

[Anonymous].  2016.  Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.. Journal of gastroenterology and hepatology. 31(3):628-33.

Combined liver-kidney transplantation for polycystic liver and kidney disease: analysis from the United Network for Organ Sharing dataset.

Combined liver-kidney transplantation for polycystic liver and kidney disease: analysis from the United Network for Organ Sharing dataset.

[Anonymous].  2016.  Combined liver-kidney transplantation for polycystic liver and kidney disease: analysis from the United Network for Organ Sharing dataset.. Liver international : official journal of the International Association for the Study of the Liver. 36(7):1018-25.

Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database.

Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database.

[Anonymous].  2016.  Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database.. HPB : the official journal of the International Hepato Pancreato Biliary Association. 18(1):29-34.

Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.

Donor positive blood culture is associated with delayed graft function in kidney transplant recipients: a propensity score analysis of the UNOS database.

Donor positive blood culture is associated with delayed graft function in kidney transplant recipients: a propensity score analysis of the UNOS database.

[Anonymous].  2016.  Donor positive blood culture is associated with delayed graft function in kidney transplant recipients: a propensity score analysis of the UNOS database.. Clinical transplantation. 30(4):415-20.

Simeprevir and sofosbuvir with or without ribavirin to treat recurrent genotype 1 hepatitis C virus infection after orthotopic liver transplantation.

Simeprevir and sofosbuvir with or without ribavirin to treat recurrent genotype 1 hepatitis C virus infection after orthotopic liver transplantation.

[Anonymous].  2016.  Simeprevir and sofosbuvir with or without ribavirin to treat recurrent genotype 1 hepatitis C virus infection after orthotopic liver transplantation.. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 22(5):635-43.